Differential distribution of HLA-DQβ/DRβ epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): Identification of DQβ epitopes associated with susceptibility to and protection from AIDP

Journal of Immunology

Volumn 170, Issue 6, 2003, Pages 3074-3080

  Magira, Eleni E ^a   Papaioakim, Miltiadis ^b   Nachamkin, Irving ^a   Asbury, Arthur K ^a   Li, Chun Y ^c   Ho, Tony W ^d   Griffin, John W ^d   McKhann, Guy M ^d,e   Monos, Dimitri S ^a,b,f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c Hebei Medical School   (China)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ALLELISM; ARTICLE; CAMPYLOBACTER JEJUNI; CHINA; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; GENE FREQUENCY; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MOLECULAR RECOGNITION; NEUROPATHY; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0347927276     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.6.3074     Document Type: Article

References (57)

1. Ho, T. W., G. M. McKhann, and J. M. Griffin. 1998. Human autoimmune neuropathies. Annu. Rev. Neurosci. 21:187.
2. Alter, M. 1990. The epidemiology of Guillain-Barré syndrome. Ann. Neurol. 27(Suppl.):S7.
3. Peterman, A. F., D. D. Daly, F. R Dion, and H. M. Keith. 1959. Infectious neuronitis (Guillain-Barré syndrome) in children. Neurology 9:533.
4. Asbury, A. K., B. G. Arnason, and R. D. Adams. 1969. The inflammatory lesion in idiopathic polyneuritis. Medicine 48:173.
5. Prineas, J. W. 1972. Acute idiopathic polyneuritis: an electron microscope study. Lab. Invest. 26:133.
6. McKhann, G. M., D. R. Cornblath, J. W. Griffin, T. W. Ho, C. Y. Li, Z. Jiang, H. S. Wu, G. Zhaori, Y. Liu, L. P. Jou, et al. 1993. Acute motor axonal neuropathy: a frequent cause of acute flacid paralysis in China. Ann. Neurol. 33:333.
7. Griffin, J. W., C. Y. Li, T. W. Ho, M. Tian, C. Y. Gao, P. Xue, B. Mishu, D. R. Cornblath, C. Macko, G. M. McKhann, et al. 1996. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann. Neurol. 39:17.
8. Fisher, M. 1956. An unusual variant of acute idiopathic polioneuritis (syndrome of ophthalmoplegia ataxia and areflexia). N. Engl. J. Med. 255:57.
9. Griffin, J. W., C. Y. Li, T. W. Ho, P. Xue, C. Macko, C. Y. Gao, C. Yang, M. Tian, B. Mishu, and D. R. Cornblath. 1995. Guillain-Barré syndrome in northern China: the spectrum of neuropathologic changes in clinically defined cases. Brain 118:577.
10. Arnason, B. G. W., and B. Soliven. 1993. Acute inflammatory demyelinating polyradiculopathy. In: Peripheral Neuropathy. P. J. Dyck, P. K. Thomas, J. W. Griffin, P. A. Low, and J. F. Poduslo, eds. Saunders, Philadelphia, p. 1437.
11. Hartung, H. P., G. Stoll, and K. V. Toyka. 1993. Immune reactions in the peripheral nervous system. In: Peripheral Neuropathy. P. J. Dyck, P. K. Thomas, J. W. Griffin, P. A. Low, and J. F. Poduslo, eds. Saunders, Philadelphia, p. 418.
12. Hartung, H. P., J. D. Pollard, G. K. Harvey, and K. V. Toyka. 1995. Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I. Muscle Nerve 18:137.
13. Hafer-Macko, C., K. A. Sheikh, C. Y. Li, T. W. Ho, D. R. Cornblath, G. M. McKhann, A. K. Asbury, and J. W. Griffin. 1996. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39:625.
14. Feasby, T. E., J. J. Gilbert, W. F. Brown, C. F. Bolton, A. F. Hahn, W. F. Koopman, and D. W. Zochodne. 1986. An acute axonal form of Guillain-Barré polyneuropathy. Brain 109:1115.
15. Feasby, T. E., A. F. Hahn, W. F. Brown, C. F. Bolton, J. J. Gilbert, and W. J. Koopman. 1993. Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? J. Neurol. Sci. 116:85.
16. Hafer-Macko, C., S. T. Hsieh, C. Y. Li, T. W. Ho, K. A. Sheikh, D. R. Cornblath, G. M. McKhann, A. K. Asbury, and J. W. Griffin. 1996. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40:635.
17. Scully, R., E. J. Mark, W. F. McNeely, S. H. Ebeling, L. D. Phillips, and S. M. Ellender. 1999. Case 39-1999. N. Engl. J. Med. 26:1996.
18. Nachamkin, I., B. M. Allos, and T. W. Ho. 2000. Campylobacter jejuni infection and the association with Guillain-Barré syndrome. In: Campylobacter, 2nd Ed. I. Nachamkin and M. J. Blaser, eds. ASM Press, Washington, D.C., p. 155.
19. Yuki, N., S. Handa, T. Taki, T. Kasama, M. Takahashi, and K. Saito. 1992. Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barré syndrome: molecular mimicry between ganglioside GM1 and lipopolysaccharide from Penner's serotype 19 Campylobacter jejuni. Biomed. Res. 13:451.
20. Yuki, N., T. Taki, F. Inagaki, T. Kasama, M. Takahashi, K. Saito, S. Handa, and T. Miyatake. 1993. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1771.
21. Tauxe, R. V. 1992. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In Campylobacter jejuni: Current Status and Future Trends. I. Nachamkin, M. J. Blaser, and L. S. Tompkins, eds. American Society for Microbiology, Washington, D.C., pp. 9-19.
22. Sheikh, K. A., I. Nachamkin, T. W. Ho, H. J. Willison, J. Veitch, B. S. Ung, C. Y. Li, B. G. Shen, D. R. Cornblath, A. K. Asbury, et al. 1998. Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology 51:2.:371.
23. Stewart, G. J., J. D. Pollard, J. G. McLeod, and C. M. Wolnizer. 1978. HLA antigens in the Landry-Guillain-Barré syndrome and chronic relapsing polyneuritis. Ann. Neurol. 4:285.
24. Latovitzki, N., N. Suciu Foca, A. S. Penn, M. R. Olarte, and A. M. Chutorian. 1979. HLA typing and Guillain-Barré syndrome. Neurology 29:743.
25. Kaslow, R. A., J. Z. Sullivan-Bolyai, B. Hafkin, L. B. Schonberger, L. Kraus, M. J. Moore, E. Yunis, and R. M. Williams. 1984. HLA antigens in Guillain-Barré syndrome. Neurology 34:240.
26. Winer, J. B., D. Briggs, K. Welsh, and R. A. C. Hughes. 1988. HLA antigens in the Guillain Barré syndrome. J. Neuroimmunol. 18:1.:13.
27. Gorodezky, C., B. Varela, L. E. Castro-Escobar, Chavez-Negrete, A. Escobar-Gutierrez, and Martinez-Mata, J. 1983. HLA-DR antigens in Mexican patients with Guillain-Barré syndrome. J. Neuroimmunol. 4:1.
28. Rees, J. H., R. W. Vaughan, E. Kondeatis, and R. A. C. Hughes. 1995. HLA-class II in Guillain-Barré syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J. Neuroimmunol. 62:53.
29. Ho, T. W., H. Willison, I. Nachamkin, C. Y. Li, J. Veitch, H. Ung, G. R. Wang, R. C. Liu, D. R. Cornblath, A. K. Asbury, et al. 1999. Anti-GD1a antibody distinguishes axonal from demyelinating forms of Guillain-Barré syndrome. Ann. Neurol. 45:168.
30. Asbury, A. K., and D. R. Cornblath. 1990. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27(Suppl.):S21.
31. Walsh, P. S., D. A. Metzger, and R. Higuchi. 1991. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Bio-Techniques 10:506.
32. Vaughan, R. W., J. S. Lanchbury, S.G. Marsh, M. A. Hall, J. G. Bodmer, and K. I. Welsh. 1990. The application of oligonucleotide probes to HLA class II typing of the DRB sub-region. Tissue Antigens 36:149.
33. Obata, F., K. Ito, T. Kaneko, Y. G. Yang, K. Onda, I. Ito, N. Yabe, K. Watanabe, and N. Kashiwagi. 1991. HLA-DR gene frequencies in the Japanese population obtained by oligonucleotide genotyping. Tissue Antigens 38:124.
34. Bugawan, T. L., A. B. Begovich, and H. A. Erlich. 1990. Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes. Immunogenetics 32:231.
35. Ballas, M., G. Oechsle, T. H. Eiermann, C. Muller, A. Wopl, and S. F. Goldmann. 1992. A DRB oligonucleotide typing system defining 50 of 56 DRB alleles. In: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. K. Tsuji, M. Aizawa, and T. Sasazuki, eds. Oxford University Press, New York, p. 311.
36. Svejgaard, A., and L. P. Ryder. 1994. HLA and disease associations: detecting the strongest association. Tissue Antigens 43:18.
37. Gao, X., Y. Sun, J. An, M. Fernandez-Vina, J. Qou, L. Lin, and P. Stastny. 1991. DNA typing for HLA-DR, -DQ, and -DP alleles in a Chinese population using the polymerase chain reaction (PCR) and oligonucleotide probes. Tissue Antigens 38:24.
38. Hammer, J., F. Gallazzi, E. Bono, R. W. Karr, J. Guenot, P. Valsasnini, Z. A. Nagy, and R. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181:1847.
39. Fu, X. T., C. P. Bono, S. L. Woulfe, C. Swearingen, N. L. Summers, R. Sinigagalia, A. Sette, B. D. Schwartz, and R. W. Karr. 1995. Pocket 4 of the HLA-DR (α,β*0401) molecule is a major determinant of T cells recognition of peptide. J. Exp. Med. 181:915.
40. McNicholl, J. M., W. C. Whiteworth, F. Oftung, X. Fu, T. Shinnick, P. E. Jensen, M. Simon, R. M. Wohlhueter, and R. W. Karr. 1995. Structural requirements of peptide and MHC for DRα,β I*0401-restricted T cell antigen recognition. J. Immanol. 15:1951.
41. Zerva, L., B. Cizman, N. K. Mehra, S. K. Alahri, R. Murali, C. M. Zmijewski, M., Kamoun, and D. S. Monos. 1996. Arginine at positions 13 or 70-71 in pocket 4 of HLA-DRB1 alleles is associated with susceptibility to tuberculoid leprosy. J. Exp. Med. 183:829.
42. Gregersen, P. K., J. Silver, and R. J. Winchester. 1987. The Shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis Rheum. 30:1205.
43. Nepom, G. T. 1995. Class II antigens and disease susceptibility. Annu. Rev. Med. 46:17.
44. Zanelli, E., F. C. Breedveld, R. R. P. de Vries. 2000. HLA class II association with rheumatoid arthritis: facts and interpretations. Hum. Immuol. 61:1254.
45. Rossman, M. D., J. Stubbs, W. W. Lee, E. Argyris, E. Magira, and D. Monos. 2002. HLA Amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am. J. Respir. Crit. Care Med. 165:788.
46. Todd, J., J. I. Bell, and H. O. McDevitt. 1988. HLA antigens and insulin-dependent diabetes. Nature 333:710.
47. Zanelli, E., C. J. Krco, J. M Baisch, S. Cheng, and C. S. David. 1996. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 93:1814.
48. Miyazaki, T., M. Uno, M. Uehira, H. Kikutani, T. Kishimoto, M. Kimoto, H. Nishimoto, J. Miyazaki, and K. Yamamura. 1990. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature 345:722.
49. k transgenic mice. Nature 345:724.
50. Lund, T., L. O'Reilly, P. Hutchings, O. Kanagauva, E. Simpson, R. Gravely, P. Chandler, J. Dyson, J. K. Picard, A. Edwards, et al. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature 345:727.
51. Das, P., D. S., D. S. Bradlley, A. Geluk, M. M. Griffiths, H. S. Luthra, C. S. David. 1999. HLA-DRBI*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Hum. Immunol. 60:575.
52. Fernandez-Vina, M. A., X. Gao, M. E. Moraes, J. R. Moraes, I. Salatiel, S. Miller, J. Tsai, Y. Sun, J. An, Z. Layrisse, et al. 1991. Alleles at four HLA class II loci determined by oligonucleotide hybridization and their associations in five ethic groups. Immunogenetics 34:299.
53. MHC Sequencing Consortium. 1999. Complete sequence and gene map of a human major histocompatibility complex. Nature 401:829.
54. Monos, D. S., M. Kamoun, I. A. Udalova, E. Csanky, B. Cizman, R. L. Tutetskaya, J. B. Smimova, V. G. Zharkov, D. Gasser, C. M. Zmijewski, et al. 1995. Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus: linkage disequilibrium of TNFab: microsatellite alleles with HLA haplotypes. Hum. Immunol. 44:70.
55. Matsuzaka, Y., S. Makino, K. Nakajima, M. Tomizawa, A. Oka, M. Kimura, S. Bahram, G. Tamiya, and H. Inoko. 2000. New polymorphic microsatellite markers in the human MHC class II region. Tissue Antigens 56:492.
56. Yuki, N., M. Takahashi, Y. Tagawa, K. Kashiwasw, K. Tadokoro, and K. Saito. 1997. Association of Campylobacter jejuni serotype and antiganglioside antibody in Guillen-Barré syndrome and Fisher's syndrome. Ann. Neurol. 42:28.
57. Goodyear, C., S. O'Hanlon, G. M. Plomp, J. J. Wagner, E. R. Morrison, L. Veitch, J. Cochrane, L. Bullens, R. W. M. Molenaar, P. C. Conner, et al. 1999. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J. Clin. Invest. 104:697.